Clinical Trial Results:
A randomised, double blind study to evaluate the safety and
efficacy of the p38 kinase inhibitor, GW856553, in subjects with
neuropathic pain from peripheral nerve injury.
Estudio aleatorizado, doble ciego para evaluar la seguridad y la eficacia de GW856553, un inhibidor de la quinasa p38, en sujetos con dolor neuropático por lesión de nervio periférico.
Summary
|
|
EudraCT number |
2009-010091-17 |
Trial protocol |
ES SE DK GB |
Global completion date |
19 Jul 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
12 Feb 2016
|
First version publication date |
13 Nov 2014
|
Other versions |
|
Summary report(s) |
112967-Clinical-Study-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.